You have 9 free searches left this month | to do more
Showing 1 - 25 of
723 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
Recruiting
  • High Grade Myelodysplastic Syndromes
  • Aurora, Colorado
    Universtiy of Colorado Denver
2021-10-19
Oct 19, 2021
F
A Study of FF-10501-01 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome
Withdrawn
  • Myelodysplastic Syndrome (MDS)
  • (no location specified)
2021-07-20
Jul 20, 2021
N
Pevonedistat With Azacitidine Versus Azacitidine Alone in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Los Angeles, California
  • +3 more
2021-08-21
Aug 21, 2021
H
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
Recruiting
  • Myeloid Malignancy
  • azacitidine
  • Detroit, Michigan
    Henry ford hospital
2021-12-23
Dec 23, 2021
N
A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.
Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
2021-12-13
Dec 13, 2021
P
Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma
Not yet recruiting
  • T-cell Lymphoma
  • Tucidinostat, Azacitidine combined with CHOP
  • (no location specified)
2021-10-09
Oct 9, 2021
U
Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
Active, not recruiting
  • Acute Myeloid Leukemia
  • Azacitidine and Venetoclax
  • Aurora, Colorado
    University of Colorado Denver
2021-10-12
Oct 12, 2021
P
Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia
Not yet recruiting
  • Acute Myeloid Leukemia, Adult
  • ADI-PEG 20
  • Houston, Texas
    MD Anderson Cancer Center
2021-08-11
Aug 11, 2021
W
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
Active, not recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-06-15
Jun 15, 2021
U
Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms
Not yet recruiting
  • Myeloproliferative Neoplasm
  • BCR-ABL Negative
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-09-29
Sep 29, 2021
M
Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Active, not recruiting
  • Large B-Cell Diffuse Lymphoma
  • Charleston, South Carolina
    Medical University of South Carolina
2021-11-04
Nov 4, 2021
I
A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
2021-11-21
Nov 21, 2021
R
Azacitidine and Pembrolizumab in Pancreatic Cancer
Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
2021-10-20
Oct 20, 2021
M
Azacitidine and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome
Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Azacitidine
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-06
Oct 6, 2021
T
Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Anti-PD-1 monoclonal antibody
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
2021-12-21
Dec 21, 2021
G
Study Evaluating the Safety and Effectiveness Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia (AML)
Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
2021-12-08
Dec 8, 2021
U
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
Recruiting
  • Breast Cancer Female
  • Breast Cancer Invasive
  • Azacitidine
  • Chicago, Illinois
  • +1 more
2021-11-19
Nov 19, 2021
L
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
2021-10-07
Oct 7, 2021
U
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
2021-02-19
Feb 19, 2021
M
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
Recruiting
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
2021-06-21
Jun 21, 2021
S
Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
2021-11-29
Nov 29, 2021
N
Pharmacokinetics, Tolerability and Safety of NEX-18a
Recruiting
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • NEX-18a injection
  • Azacitidine Injection
  • Huddinge, Sweden
  • +1 more
2021-09-09
Sep 9, 2021
C
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid - 2021
Completed
  • Myelodysplastic Syndromes
  • +2 more
  • Azacitidine
  • Ascorbic acid
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
2021-08-04
Aug 4, 2021
A
APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS)
Recruiting
  • MDS
  • Myelodysplastic Syndromes
  • APR-548 + Azacitidine
  • Tampa, Florida
  • +3 more
2021-10-01
Oct 1, 2021
U
Study of Azacitidine and Durvalumab in Advanced Solid Tumors - 2020
Completed
  • Microsatellite Stable Colorectal Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-03-30
Mar 30, 2021